NASDAQ: HSDTHelius Medical Technologies Inc Stock
$5.94-0.04 (-0.67%)
Updated Oct 31, 2025
HSDT Price
$5.94
Fair Value Price
-$2.29
Market Cap
$6.40M
52 Week Low
$5.37
52 Week High
$1,200.00
P/E
0x
P/B
1.06x
P/S
3.81x
PEG
N/A
Dividend Yield
N/A
Revenue
$295.00k
Earnings
-$21.29M
Gross Margin
-89.2%
Operating Margin
-6,998.98%
Profit Margin
-7,215.3%
Debt to Equity
0.31
Operating Cash Flow
-$11M
Beta
1.26
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
HSDT Overview
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine HSDT's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important HSDT news, forecast changes, insider trades & much more!
HSDT News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HSDT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HSDT ($5.94) is overvalued by 359.18% relative to our estimate of its Fair Value price of -$2.29 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
HSDT ($5.94) is not significantly undervalued (359.18%) relative to our estimate of its Fair Value price of -$2.29 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
HSDT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more HSDT due diligence checks available for Premium users.
Valuation
HSDT fair value
Fair Value of HSDT stock based on Discounted Cash Flow (DCF)
Price
$5.94
Fair Value
-$2.29
Undervalued by
359.18%
HSDT ($5.94) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HSDT ($5.94) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HSDT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
HSDT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
27.18x
Market
41.55x
HSDT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.06x
Industry
3.86x
HSDT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
HSDT's financial health
Profit margin
Revenue
$43.0k
Net Income
-$9.8M
Profit Margin
-22,867.4%
HSDT's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
HSDT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$7.9M
Liabilities
$1.9M
Debt to equity
0.31
HSDT's short-term assets ($7.80M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HSDT's short-term assets ($7.80M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HSDT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HSDT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.8M
Investing
$0.0
Financing
$7.7M
HSDT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
HSDT vs Medical Device Stocks
Helius Medical Technologies Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.